Ratan Capital Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-219,575
Closed -$58.9M 11
2016
Q1
$58.9M Sell
219,575
-182,911
-45% -$52.4M 20.85% 3
2015
Q4
$126M Buy
402,486
+213,942
+113% +$63.7M 27.79% 1
2015
Q3
$51.2M Sell
188,544
-204,649
-52% -$62.9M 11.2% 5
2015
Q2
$119M Hold
393,193
11.37% 2
2015
Q1
$117M Sell
393,193
-590
-0.1% -$168K 16.45% 2
2014
Q4
$101M Sell
393,783
-48,066
-11% -$12M 28.98% 1
2014
Q3
$107M Buy
441,849
+140,354
+47% +$31.4M 19.65% 1
2014
Q2
$67.2M Hold
301,495
9.53% 4
2014
Q1
$62.1M Buy
+301,495
New +$59.7M 15.14% 3
2013
Q4
Sell
-61,175
Closed -$8.81M 31
2013
Q3
$8.81M Buy
+61,175
New +$8.15M 2.62% 17

Other funds holding AGN

Ratan Capital Management's AGN Position: Q2 2016 in Review

Ratan Capital Management sold out of Allergan plc (AGN) in Q2 2016, closing a stake of 219,575 shares — an estimated $58.9M sold.

Ratan Capital Management first reported a position in AGN in Q3 2013 and held it in 10 quarters. The position peaked at $126M in Q4 2015. 1,107 funds tracked by Wall St. Rank hold AGN as of Q2 2016.

  • Ratan Capital Management reported no remaining Allergan plc position as of Q2 2016 after selling out during the quarter.
  • Ratan Capital Management sold 219,575 Allergan plc shares in Q2 2016, an estimated $58.9M.
  • Ratan Capital Management first reported a position in Allergan plc in Q3 2013 and held it in 10 quarters.
  • Ratan Capital Management's Allergan plc position peaked at $126M in Q4 2015.
  • 1,107 funds tracked by Wall St. Rank held Allergan plc as of Q2 2016.

Based on Ratan Capital Management's 13F filing for Q2 2016, filed 15 Aug 2016.